Genpact stock faces a November 10 Delaware vote

Published on 10/08/2026 at 01:36 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Genpact stock closed at USD 33.65 on October 7, 2026, up 0.60 percent. A 12-analyst Buy consensus puts the average target at USD 42.18.

Genpact, BMG3922B1072, Illustration mit AI erstellt.

Genpact Limited stock (ISIN BMG3922B1072) closed at USD 33.65 on the NYSE on October 7, 2026, up 0.60 percent from the prior close. The company has filed a Delaware domestication proposal ahead of a shareholder vote scheduled for November 10, 2026, according to StockTitan on October 7, 2026.

Delaware vote sets next checkpoint

The proposal would move Genpact's jurisdiction of incorporation from Bermuda to Delaware while preserving each shareholder's proportional ownership. The filing states that 167,227,006 common shares were outstanding and entitled to vote as of September 30, 2026.

The special meeting is set for November 10, 2026, and the proposed transaction is expected to become effective on or around March 1, 2027, subject to shareholder and board approval, according to StockTitan. The filing also notes that Delaware law would change certain shareholder rights, including the threshold for calling a special meeting.

Q2 revenue grew 7.1 percent

Genpact reported USD 1.34 billion of Q2 2026 revenue, up 7.1 percent year over year, and adjusted earnings per share of USD 1.00 versus a USD 0.97 estimate, according to Yahoo Finance. The finance and technology services company also reported USD 145.74 million of quarterly earnings in the same period.

Advanced Technology Solutions revenue reached USD 363 million in Q2 2026, up 24.1 percent year over year, while full-year growth guidance for that business was at least 25 percent. Genpact also guided to Q3 revenue of USD 1.369 billion to USD 1.382 billion and adjusted EPS of USD 1.04 to USD 1.05, according to Yahoo Finance.

Consensus target remains above the stock

A 12-analyst consensus rated Genpact Buy and set an average 12-month price target of USD 42.18, with a high target of USD 58.00 and a low target of USD 31.00, according to Investing.com. The average target lies 25.35 percent above the October 7 price, making the Delaware vote and the next earnings update the clearest dated checkpoints for investors.

Stock stays below its yearly high

Genpact's October 7 closing price of USD 33.65 sat within a session range of USD 33.07 to USD 34.36 and a 52-week range of USD 26.85 to USD 48.64. Market capitalization was USD 5.6 billion and volume was 1,706,484 shares for the session.